General Information of Drug (ID: DM83MOK)

Drug Name
Glassia Drug Info
Synonyms Glassia (TN)
Indication
Disease Entry ICD 11 Status REF
Emphysema CA21 Approved [1]
Cross-matching ID
TTD Drug ID
DM83MOK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zemaira DMA5QPM Emphysema CA21 Approved [3]
Igmesine DMH97XA Major depressive disorder 6A70.3 Phase 2 [4]
AGTC-0106 DMMKASG Alpha-1 antitrypsin deficiency 5C5A Phase 2 [5]
2-Sulfhydryl-Ethanol DMJBO3D Discovery agent N.A. Investigative [6]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Alpha-1-antitrypsin (SERPINA1) TTA7UJC A1AT_HUMAN Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7487).
2 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
4 Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
5 First gene therapy nears landmark European market authorization. Nat Biotechnol. 2012 Sep;30(9):807-9.
6 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.